Schubert & Co’s Exelixis EXEL Stock Holding History

Schubert & Co’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-111	Closed	-$2.15K	–	533
2023 Q1	$2.15K	Buy	111 +41	+59%	+$714	﹤0.01%	881
2022 Q4	$1.12K	Buy	70 +6	+9%	+$98	﹤0.01%	1129
2022 Q3	$1K	Sell	64 -32	-33%	-$618	﹤0.01%	1087
2022 Q2	$2K	Buy	96 +47	+96%	+$969	﹤0.01%	758
2022 Q1	$1K	Buy	49 +24	+96%	+$469	﹤0.01%	673
2021 Q4	$0	Buy	+25	New	+$478	﹤0.01%	1086

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Schubert & Co's EXEL Position: Q2 2023 in Review

Schubert & Co sold out of Exelixis (EXEL) in Q2 2023, closing a stake of 111 shares — an estimated $2.15K sold.

Schubert & Co first reported a position in EXEL in Q4 2021 and held it in 6 quarters. The position peaked at $2.15K in Q1 2023. 378 funds tracked by Wall St. Rank hold EXEL as of Q2 2023.

Schubert & Co reported no remaining Exelixis position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 111 Exelixis shares in Q2 2023, an estimated $2.15K.
Schubert & Co first reported a position in Exelixis in Q4 2021 and held it in 6 quarters.
Schubert & Co's Exelixis position peaked at $2.15K in Q1 2023.
378 funds tracked by Wall St. Rank held Exelixis as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.